MEGAN FISHER: Open Payments
NPI 1144854779 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 55 payments from 16 companies in 2025. Trend: 2023 $825 · 2024 $1,459 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $245 |
| ABBVIE INC. | 10 | $136 |
| Almatica Pharma LLC | 7 | $120 |
| Corium, LLC | 5 | $83 |
| Bausch Health US, LLC | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Lundbeck LLC | 3 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
Products named: REXULTI, VRAYLAR, LOREEV XR, Azstarys, APLENZIN, CAPLYTA, INGREZZA, Auvelity.
Industry payments across IN — which companies pay providers there.
